Seres Therapeutics (MCRB)

5.67 -0.57 (9.13%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (3/8/19 *Est.)

Latest Headlines

Foghorn® Therapeutics appoints Carl P. Decicco, Ph.D. as Chief Scientific Officer December 13, 2018 7:00 AM - BizWire Research Report Identifies OraSure Technologies, Sierra Wireless, Seres Therapeutics, Lydall, ChromaDex, and Capricor Therapeutics with Renewed Outlook — Fundamental Analysis, Calculating Forward Mo November 28, 2018 8:35 AM - Globe NewsWire Form 8-K Seres Therapeutics, Inc. For: Nov 16 November 21, 2018 8:50 AM - SEC Filing Form 4 Seres Therapeutics, Inc. For: Nov 15 Filed by: Aunins John G. November 19, 2018 4:33 PM - SEC Filing Flagship Pioneering Names Ryan Watts, CEO of Denali Therapeutics, as Recipient of the 2018 Pioneering Leader Award November 15, 2018 8:00 AM - PR NewsWire Seres Therapeutics (MCRB) PT Lowered to $16 at Oppenheimer November 9, 2018 8:57 AM - StreetInsider Seres Therapeutics to Present at the Stifel 2018 Healthcare Conference November 9, 2018 7:00 AM - BizWire Form 10-Q Seres Therapeutics, Inc. For: Sep 30 November 8, 2018 10:13 AM - SEC Filing Seres Therapeutics (MCRB) Misses Q3 EPS by 2c, Revenues Miss November 8, 2018 7:13 AM - StreetInsider Form 8-K Seres Therapeutics, Inc. For: Nov 08 November 8, 2018 7:05 AM - SEC Filing Seres Therapeutics Reports Third Quarter Financial Results and Provides Operational Updates November 8, 2018 7:00 AM - BizWire Form 8-K Seres Therapeutics, Inc. For: Nov 01 November 7, 2018 4:16 PM - SEC Filing Seres Therapeutics to Host Third Quarter 2018 Financial Results and Operational Progress Conference Call and Webcast on November 8, 2018 November 5, 2018 7:00 AM - BizWire Form 4 Seres Therapeutics, Inc. For: Oct 23 Filed by: HORGAN KEVIN October 24, 2018 5:59 PM - SEC Filing Form 3 Seres Therapeutics, Inc. For: Oct 22 Filed by: HORGAN KEVIN October 24, 2018 5:58 PM - SEC Filing Form 8-K Seres Therapeutics, Inc. For: Oct 17 October 22, 2018 7:05 AM - SEC Filing Seres Therapeutics Announces Appointment of Kevin Horgan, M.D., as Chief Medical Officer October 22, 2018 7:00 AM - BizWire UPDATE: Chardan Capital Markets Starts Seres Therapeutics (MCRB) at Buy October 22, 2018 6:00 AM - StreetInsider Form 4 Seres Therapeutics, Inc. For: Oct 15 Filed by: Aunins John G. October 16, 2018 4:17 PM - SEC Filing Seres Therapeutics to Present New Data Supporting SER-109 Clinical Activity at IDWeek 2018 October 3, 2018 7:00 AM - BizWire Form 4 Seres Therapeutics, Inc. For: May 15 Filed by: Aunins John G. September 19, 2018 9:23 PM - SEC Filing Full Article List